<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>health equity on Arun Mitra</title>
    <link>https://arunmitra.com/tags/health-equity/</link>
    <description>Recent content in health equity on Arun Mitra</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Wed, 09 Jul 2025 00:00:00 +0000</lastBuildDate><atom:link href="https://arunmitra.com/tags/health-equity/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Enhancing Access to Antimicrobial Resistance Diagnostics for the Marginalised</title>
      <link>https://arunmitra.com/research/amr-diagnostics-poct/</link>
      <pubDate>Wed, 09 Jul 2025 00:00:00 +0000</pubDate>
      
      <guid>https://arunmitra.com/research/amr-diagnostics-poct/</guid>
      <description>Background     Antimicrobial resistance (AMR) is a growing threat in low- and middle-income countries, yet access to reliable diagnostics remains deeply unequal. Marginalised populations, particularly in rural, tribal, and remote settings, are least likely to reach laboratories capable of culture and susceptibility testing, leaving treatment to empirical and often inappropriate antibiotic use. This work, conducted under the EquityAMR initiative in India, examines the AMR diagnostic access gap for marginalised communities and the role point-of-care technologies could play in closing it.</description>
    </item>
    
    <item>
      <title>Geo-Spatial Analysis of Acute Ischemic Stroke Reperfusion Treatment in India</title>
      <link>https://arunmitra.com/research/stroke-reperfusion-access/</link>
      <pubDate>Sun, 01 Jun 2025 00:00:00 +0000</pubDate>
      
      <guid>https://arunmitra.com/research/stroke-reperfusion-access/</guid>
      <description>Background     Acute ischaemic stroke is a time-critical emergency in which reperfusion therapy, intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT), must be delivered within a narrow therapeutic window to salvage brain tissue. In a country as large and geographically heterogeneous as India, the practical benefit of these treatments depends not only on whether capable centres exist but on whether patients can physically reach them in time. This study asks a simple but consequential question: what share of India&amp;rsquo;s population actually lives within a one-hour drive of a stroke centre equipped to deliver IVT or EVT, and how does that access vary across regions?</description>
    </item>
    
  </channel>
</rss>
